Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hong Kong Pharma Digital Technology Holdings Ltd. ( (HKPD) ) has shared an announcement.
On March 28, 2025, Hong Kong Pharma Digital Technology Holdings Ltd. released its unaudited interim consolidated financial statements for the six months ended September 30, 2024, showing a significant increase in revenues and net profit compared to the same period in 2023. The company’s revenue rose to $11.09 million from $7.01 million, and net profit increased to $828,559 from $249,037, indicating strong operational performance and growth. This financial improvement highlights the company’s strengthened position in the market and potential for future expansion, positively impacting stakeholders’ confidence.
More about Hong Kong Pharma Digital Technology Holdings Ltd.
Hong Kong Pharma Digital Technology Holdings Ltd. operates in the pharmaceutical and digital technology industry, focusing on the development and distribution of pharmaceutical products and digital health solutions. The company is based in Hong Kong and aims to leverage digital technology to enhance healthcare delivery and patient outcomes.
YTD Price Performance: -54.61%
Average Trading Volume: 271,126
Find detailed analytics on HKPD stock on TipRanks’ Stock Analysis page.